Advisor Group Holdings, Inc. Fate Therapeutics Inc Transaction History

Advisor Group Holdings, Inc.

  • $67.1 Billion
  • Q3 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 2,785 shares of FATE stock, worth $2,673. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,785
Previous 3,385 17.73%
Holding current value
$2,673
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$0.92 - $1.3 $552 - $780
-600 Reduced 17.73%
2,785 $3,000
Q2 2025

Sep 04, 2025
SELL
$0.68 - $1.67 $180 - $442
-265 Reduced 7.26%
3,385 $3,000
Q2 2025

Aug 13, 2025
BUY
$0.68 - $1.67 $982 - $2,413
1,445 Added 65.53%
3,650 $4,000
Q1 2025

May 12, 2025
BUY
$0.79 - $1.87 $1,267 - $3,001
1,605 Added 267.5%
2,205 $1,000
Q4 2024

Jun 06, 2025
BUY
$1.61 - $3.35 $1,779 - $3,701
1,105 Added 50.11%
3,310 $5,000
Q4 2024

Feb 07, 2025
SELL
$1.61 - $3.35 $4,205 - $8,750
-2,612 Reduced 81.32%
600 $0
Q3 2024

Nov 13, 2024
SELL
$3.12 - $5.57 $5,341 - $9,535
-1,712 Reduced 34.77%
3,212 $11,000
Q2 2024

Aug 13, 2024
SELL
$3.26 - $7.08 $101 - $219
-31 Reduced 0.63%
4,924 $16,000
Q1 2024

May 10, 2024
BUY
$3.54 - $8.35 $361 - $851
102 Added 2.1%
4,955 $36,000
Q4 2023

Feb 12, 2024
SELL
$1.65 - $3.94 $389 - $929
-236 Reduced 4.64%
4,853 $18,000
Q3 2023

Nov 13, 2023
SELL
$2.02 - $5.04 $2,537 - $6,330
-1,256 Reduced 19.8%
5,089 $10,000
Q2 2023

Aug 10, 2023
SELL
$4.76 - $6.59 $1,042 - $1,443
-219 Reduced 3.34%
6,345 $30,000
Q1 2023

May 12, 2023
BUY
$4.24 - $11.12 $818 - $2,146
193 Added 3.03%
6,564 $37,000
Q4 2022

Feb 10, 2023
BUY
$9.86 - $23.83 $52,691 - $127,347
5,344 Added 520.35%
6,371 $64,000
Q3 2022

Nov 14, 2022
BUY
$21.04 - $36.06 $4,544 - $7,788
216 Added 26.63%
1,027 $22,000
Q2 2022

Aug 10, 2022
SELL
$17.78 - $42.39 $3,627 - $8,647
-204 Reduced 20.1%
811 $20,000
Q1 2022

May 04, 2022
SELL
$29.67 - $60.28 $16,674 - $33,877
-562 Reduced 35.64%
1,015 $401,000
Q3 2021

Nov 05, 2021
SELL
$59.27 - $95.73 $123,992 - $200,267
-2,092 Reduced 57.02%
1,577 $94,000
Q2 2021

Aug 02, 2021
BUY
$67.25 - $92.52 $176,127 - $242,309
2,619 Added 249.43%
3,669 $320,000
Q1 2021

May 13, 2021
SELL
$72.16 - $117.4 $48,780 - $79,362
-676 Reduced 39.17%
1,050 $87,000
Q4 2020

Feb 10, 2021
SELL
$38.09 - $100.95 $140,628 - $372,707
-3,692 Reduced 68.14%
1,726 $158,000
Q3 2020

Nov 12, 2020
BUY
$30.41 - $40.5 $14,718 - $19,602
484 Added 9.81%
5,418 $197,000
Q2 2020

Aug 14, 2020
BUY
$20.21 - $35.23 $1,434 - $2,501
71 Added 1.46%
4,934 $169,000
Q1 2020

May 18, 2020
BUY
$17.28 - $31.88 $84,032 - $155,032
4,863 New
4,863 $117,000

Others Institutions Holding FATE

# of Institutions
158
Shares Held
90.4M
Call Options Held
73.9K
Put Options Held
13.4K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $93.1M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email